Institutions / Versor Investments LP

Versor Investments LP

CIK 1650301 · Institution · as of Jun 30, 2026
Portfolio value
$47.53M
Positions
27
As of
Jun 30, 2026

Portfolio trend

Portfolio value

$47.53M-92.6%
$641.75M$344.64M$47.53MQ4 '25Q2 '26

Positions

27-95.4%
59030927Q4 '25Q2 '26

Top holdings

Jun 30, 2026View all 27 →
CompanyClassValueShares% of portfolio
Nuvalent, Inc.$3.19M25,8506.7%
Janus Henderson Group PLC$3.04M58,4566.4%
BIO-TECHNE Corp$2.97M42,0506.3%
Norfolk Southern Corp$2.68M8,5325.6%
Select Medical Holdings Corp$2.68M162,3285.6%
Talkspace, Inc$2.49M478,4705.2%
Apogee Therapeutics, Inc.$2.42M18,2225.1%
Catalyst Pharmaceuticals, Inc.$2.40M76,2865.0%
Unifirst Corp$2.32M8,7824.9%
Silicon Laboratories Inc$2.30M10,5304.8%
Electronic Arts Inc.$2.24M10,9194.7%
Penumbra Inc$2.05M6,4914.3%
NCR Atleos Corp$1.91M43,9214.0%
Qorvo, Inc.$1.85M19,8363.9%
Stellar Bancorp, Inc.$1.82M46,1733.8%
Valaris Ltd$1.68M23,1763.5%
Leggett & Platt Inc$1.55M132,4553.3%
Aes Corp$1.46M99,2953.1%
Warner Bros. Discovery, Inc.$1.33M50,0682.8%
Organon & Co.$1.19M87,6402.5%
DigitalBridge Group, Inc.$879.4K55,7291.9%
Chart Industries Inc$715.6K3,4251.5%
LiveRamp Holdings, Inc.$689.9K18,3281.5%
Essential Utilities, Inc.$603.8K15,7621.3%
Dominion Energy, Inc$501.8K7,3481.1%

Activity

InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.
DateActionCompanyValueShares ΔPosition afterImpact
Q2 2026
as of
ExitCMA
Comerica Inc
Common Stock
$-18.90M-217K
-100.00%
0
medium
Q2 2026
as of
TrimJanus Henderson Group PLC
Common stock
$-17.03M-328K
-84.87%
58,456
6.39% of portfolio
medium
Q2 2026
as of
Exit171757206
Common stock
$-16.17M-73K
-100.00%
0
medium
Q2 2026
as of
TrimNorfolk Southern Corp
Common stock
$-14.20M-45K
-84.10%
8,532
5.65% of portfolio
medium
Q2 2026
as of
ExitDayforce, Inc.
Common stock
$-12.65M-183K
-100.00%
0
medium
Q2 2026
as of
ExitAmicus Therapeutics Inc
Common stock
$-12.41M-871K
-100.00%
0
medium
Q2 2026
as of
ExitExact Sciences Corp.
Common stock
$-12.26M-121K
-100.00%
0
medium
Q2 2026
as of
ExitAvidity Biosciences, Inc.
Common stock
$-11.75M-163K
-100.00%
0
medium
Q2 2026
as of
ExitConfluent, Inc.
Common stock
$-11.50M-380K
-100.00%
0
medium
Q2 2026
as of
ExitCadence Bank
Common stock
$-10.90M-254K
-100.00%
0
medium